Xin Tu
Concepts (385)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Models, Statistical | 11 | 1992 | 114 |
Why?
| Depressive Disorder | 18 | 1994 | 77 |
Why?
| Questionnaires | 20 | 2003 | 361 |
Why?
| Longitudinal Studies | 6 | 2004 | 195 |
Why?
| Depression | 10 | 2006 | 119 |
Why?
| Sex Offenses | 4 | 2005 | 26 |
Why?
| HIV Infections | 10 | 1992 | 137 |
Why?
| Psychotherapy | 10 | 1997 | 46 |
Why?
| Risk-Taking | 4 | 2006 | 37 |
Why?
| Quality of Life | 7 | 2007 | 188 |
Why?
| Data Interpretation, Statistical | 5 | 2003 | 110 |
Why?
| Urinary Catheterization | 2 | 2010 | 14 |
Why?
| Sexual Behavior | 4 | 1993 | 38 |
Why?
| Female | 65 | 1993 | 1646 |
Why?
| Health Promotion | 2 | 2009 | 77 |
Why?
| Child Abuse, Sexual | 4 | 2004 | 27 |
Why?
| Primary Health Care | 8 | 2006 | 151 |
Why?
| Depressive Disorder, Major | 6 | 2005 | 37 |
Why?
| Humans | 80 | 1992 | 1858 |
Why?
| Psychometrics | 7 | 2007 | 97 |
Why?
| Obsessive-Compulsive Disorder | 2 | 2004 | 19 |
Why?
| Adolescent | 21 | 1993 | 892 |
Why?
| Suicide, Attempted | 3 | 2007 | 42 |
Why?
| Clinical Trials as Topic | 4 | 2004 | 251 |
Why?
| Adult | 41 | 1993 | 1321 |
Why?
| Male | 48 | 1993 | 1558 |
Why?
| Sample Size | 3 | 1994 | 24 |
Why?
| Biometry | 5 | 1994 | 33 |
Why?
| Acculturation | 1 | 2011 | 9 |
Why?
| Stress, Psychological | 4 | 1997 | 118 |
Why?
| Cognitive Therapy | 2 | 1997 | 26 |
Why?
| African Americans | 2 | 2006 | 108 |
Why?
| Prejudice | 1 | 2011 | 30 |
Why?
| Pharmacies | 1 | 2010 | 6 |
Why?
| Psychiatric Status Rating Scales | 11 | 1994 | 100 |
Why?
| Neurotic Disorders | 1 | 2010 | 19 |
Why?
| Aged | 26 | 1994 | 992 |
Why?
| Sexual Abstinence | 1 | 2009 | 7 |
Why?
| Sexual Partners | 1 | 2010 | 24 |
Why?
| Aged, 80 and over | 16 | 1996 | 602 |
Why?
| Domestic Violence | 1 | 2010 | 21 |
Why?
| Markov Chains | 2 | 1999 | 25 |
Why?
| Health Status Indicators | 1 | 2010 | 68 |
Why?
| Cognition | 2 | 2010 | 98 |
Why?
| Acquired Immunodeficiency Syndrome | 4 | 1993 | 85 |
Why?
| Substance-Related Disorders | 2 | 2006 | 96 |
Why?
| Middle Aged | 33 | 1994 | 1166 |
Why?
| Pelvic Pain | 2 | 2005 | 17 |
Why?
| Sleep Initiation and Maintenance Disorders | 3 | 1997 | 20 |
Why?
| Risk Reduction Behavior | 2 | 2005 | 26 |
Why?
| Unsafe Sex | 1 | 2008 | 4 |
Why?
| Writing | 1 | 2008 | 14 |
Why?
| Adolescent Health Services | 1 | 2009 | 23 |
Why?
| Stress Disorders, Post-Traumatic | 3 | 2003 | 33 |
Why?
| Psychology | 1 | 2007 | 31 |
Why?
| Behavior Therapy | 2 | 2005 | 51 |
Why?
| Prevalence | 10 | 1994 | 282 |
Why?
| Pain | 3 | 2006 | 192 |
Why?
| Computer Simulation | 3 | 1999 | 134 |
Why?
| Suicide | 5 | 2006 | 60 |
Why?
| Self Disclosure | 1 | 2006 | 31 |
Why?
| Poverty | 2 | 2006 | 56 |
Why?
| Community Mental Health Centers | 1 | 2005 | 10 |
Why?
| Vulnerable Populations | 1 | 2006 | 19 |
Why?
| Risk Factors | 12 | 1993 | 557 |
Why?
| Attitude to Health | 1 | 2008 | 107 |
Why?
| Women's Health | 1 | 2006 | 40 |
Why?
| Clomipramine | 1 | 2005 | 2 |
Why?
| Activities of Daily Living | 6 | 1994 | 122 |
Why?
| Adolescent Psychology | 3 | 2008 | 20 |
Why?
| Sertraline | 1 | 2004 | 6 |
Why?
| Treatment Outcome | 13 | 1994 | 662 |
Why?
| Shame | 1 | 2004 | 10 |
Why?
| Antipsychotic Agents | 4 | 2005 | 49 |
Why?
| Dissociative Disorders | 1 | 2004 | 9 |
Why?
| Antidepressive Agents, Tricyclic | 1 | 2005 | 18 |
Why?
| Mass Screening | 5 | 1992 | 126 |
Why?
| Serotonin Uptake Inhibitors | 1 | 2004 | 19 |
Why?
| Research Design | 1 | 2006 | 169 |
Why?
| Spouse Abuse | 1 | 2005 | 24 |
Why?
| New York | 7 | 2005 | 425 |
Why?
| Hospitalization | 3 | 1994 | 169 |
Why?
| Patient Dropouts | 1 | 2003 | 25 |
Why?
| Pilot Projects | 5 | 2005 | 265 |
Why?
| Models, Biological | 1 | 2009 | 411 |
Why?
| Interpersonal Relations | 4 | 1997 | 74 |
Why?
| Cross-Sectional Studies | 8 | 1998 | 254 |
Why?
| Geriatric Assessment | 6 | 2006 | 63 |
Why?
| Bayes Theorem | 3 | 1996 | 24 |
Why?
| United States | 10 | 1993 | 604 |
Why?
| Clozapine | 3 | 2005 | 17 |
Why?
| Schizophrenia | 4 | 2005 | 49 |
Why?
| Mental Disorders | 4 | 1997 | 132 |
Why?
| Comorbidity | 8 | 1994 | 191 |
Why?
| Young Adult | 5 | 2009 | 381 |
Why?
| Suicidal Ideation | 2 | 2010 | 11 |
Why?
| Social Support | 5 | 2006 | 111 |
Why?
| Prospective Studies | 6 | 1994 | 547 |
Why?
| Alcohol-Related Disorders | 2 | 2010 | 17 |
Why?
| Epidemiology | 1 | 1999 | 15 |
Why?
| Motivation | 3 | 1996 | 85 |
Why?
| Diagnostic Techniques and Procedures | 1 | 1999 | 10 |
Why?
| Catheters, Indwelling | 2 | 2010 | 46 |
Why?
| Sensitivity and Specificity | 10 | 1992 | 427 |
Why?
| Predictive Value of Tests | 6 | 1996 | 322 |
Why?
| Alcohol Drinking | 2 | 2010 | 45 |
Why?
| Adolescent Behavior | 3 | 2008 | 41 |
Why?
| Logistic Models | 4 | 1997 | 254 |
Why?
| Feasibility Studies | 3 | 2005 | 144 |
Why?
| Sleep Disorders | 3 | 1997 | 32 |
Why?
| Follow-Up Studies | 6 | 2005 | 554 |
Why?
| Analysis of Variance | 5 | 1997 | 339 |
Why?
| Severity of Illness Index | 8 | 1994 | 359 |
Why?
| Cluster Analysis | 3 | 2004 | 67 |
Why?
| Outcome Assessment (Health Care) | 2 | 2010 | 164 |
Why?
| Age Factors | 6 | 1994 | 480 |
Why?
| Discriminant Analysis | 1 | 1997 | 21 |
Why?
| AIDS Serodiagnosis | 2 | 1992 | 10 |
Why?
| Zidovudine | 2 | 1993 | 23 |
Why?
| Population Surveillance | 2 | 1994 | 70 |
Why?
| Data Collection | 3 | 2003 | 137 |
Why?
| Case-Control Studies | 5 | 1998 | 284 |
Why?
| Chronic Disease | 4 | 2005 | 270 |
Why?
| Mood Disorders | 3 | 1997 | 31 |
Why?
| Child | 7 | 2004 | 750 |
Why?
| Hospitals, Psychiatric | 2 | 1994 | 13 |
Why?
| Cognition Disorders | 2 | 2007 | 108 |
Why?
| Monte Carlo Method | 3 | 1999 | 40 |
Why?
| Multivariate Analysis | 3 | 1998 | 227 |
Why?
| HIV-1 | 3 | 1992 | 93 |
Why?
| Enzyme-Linked Immunosorbent Assay | 5 | 1994 | 224 |
Why?
| Blood Specimen Collection | 1 | 1994 | 17 |
Why?
| Psychiatry | 2 | 2003 | 24 |
Why?
| CD4 Lymphocyte Count | 1 | 1994 | 50 |
Why?
| Internal-External Control | 2 | 1996 | 30 |
Why?
| Risk Assessment | 3 | 2005 | 325 |
Why?
| Reproducibility of Results | 4 | 2007 | 392 |
Why?
| Probability | 3 | 1994 | 190 |
Why?
| Lung Neoplasms | 2 | 2007 | 160 |
Why?
| Psychotic Disorders | 3 | 1997 | 38 |
Why?
| Bias (Epidemiology) | 3 | 1992 | 35 |
Why?
| Aging | 5 | 2006 | 275 |
Why?
| Combined Modality Therapy | 2 | 2004 | 219 |
Why?
| Time Factors | 6 | 1994 | 896 |
Why?
| Survival Rate | 1 | 1994 | 250 |
Why?
| Factor Analysis, Statistical | 2 | 1998 | 45 |
Why?
| Randomized Controlled Trials as Topic | 3 | 1994 | 176 |
Why?
| Perception | 1 | 2011 | 49 |
Why?
| Breast Neoplasms | 2 | 2007 | 186 |
Why?
| Life Change Events | 2 | 1996 | 51 |
Why?
| Pain Measurement | 3 | 2005 | 98 |
Why?
| 6-Aminocaproic Acid | 1 | 2010 | 6 |
Why?
| HIV Antibodies | 2 | 1999 | 16 |
Why?
| Social Control, Informal | 1 | 2010 | 6 |
Why?
| Plasma | 1 | 2010 | 25 |
Why?
| Antifibrinolytic Agents | 1 | 2010 | 12 |
Why?
| Executive Function | 1 | 2010 | 10 |
Why?
| Mental Health Services | 1 | 2010 | 38 |
Why?
| Fibrinolysis | 1 | 2010 | 17 |
Why?
| Observer Variation | 1 | 2010 | 103 |
Why?
| Equipment Failure | 1 | 2010 | 44 |
Why?
| Pain Management | 1 | 2010 | 32 |
Why?
| Ambulatory Care | 3 | 2005 | 106 |
Why?
| Health Services for the Aged | 1 | 2010 | 29 |
Why?
| Urinary Tract Infections | 1 | 2010 | 31 |
Why?
| Peer Group | 1 | 2010 | 31 |
Why?
| Outcome and Process Assessment (Health Care) | 1 | 2010 | 63 |
Why?
| Child Behavior | 1 | 2010 | 41 |
Why?
| Emotions | 1 | 2010 | 59 |
Why?
| Homosexuality, Female | 1 | 2009 | 7 |
Why?
| Spinal Cord Injuries | 1 | 2010 | 34 |
Why?
| Depression, Postpartum | 1 | 2010 | 10 |
Why?
| Mental Health | 1 | 2010 | 45 |
Why?
| Social Class | 1 | 2010 | 47 |
Why?
| Homosexuality, Male | 1 | 2009 | 13 |
Why?
| Genital Diseases, Female | 1 | 2009 | 22 |
Why?
| Work | 1 | 2008 | 6 |
Why?
| Cohort Studies | 3 | 2005 | 333 |
Why?
| Health Behavior | 1 | 2010 | 62 |
Why?
| Sex Distribution | 2 | 2006 | 101 |
Why?
| Poisson Distribution | 1 | 2008 | 18 |
Why?
| Nursing Methodology Research | 1 | 2008 | 20 |
Why?
| Personality | 1 | 2010 | 41 |
Why?
| Hot Flashes | 1 | 2008 | 16 |
Why?
| Program Evaluation | 1 | 2009 | 115 |
Why?
| Condoms | 1 | 2008 | 9 |
Why?
| Carcinoma, Ductal, Breast | 1 | 2008 | 24 |
Why?
| Internet | 1 | 2009 | 64 |
Why?
| Age Distribution | 2 | 2005 | 127 |
Why?
| Placebos | 2 | 2005 | 110 |
Why?
| Trail Making Test | 1 | 2007 | 8 |
Why?
| Immunity | 1 | 2008 | 46 |
Why?
| European Continental Ancestry Group | 2 | 2006 | 118 |
Why?
| Likelihood Functions | 2 | 1994 | 43 |
Why?
| Survivors | 1 | 2008 | 45 |
Why?
| Fatigue | 1 | 2008 | 48 |
Why?
| Diabetic Ketoacidosis | 1 | 2007 | 12 |
Why?
| Quinolones | 1 | 2007 | 17 |
Why?
| Parent-Child Relations | 1 | 2008 | 53 |
Why?
| Asian Continental Ancestry Group | 1 | 2007 | 23 |
Why?
| Sickness Impact Profile | 1 | 2007 | 26 |
Why?
| Audiovisual Aids | 1 | 2006 | 14 |
Why?
| Retrospective Studies | 3 | 2007 | 656 |
Why?
| Personality Disorders | 1 | 2007 | 30 |
Why?
| Computers | 1 | 2006 | 59 |
Why?
| Forensic Psychiatry | 1 | 2007 | 16 |
Why?
| Social Desirability | 1 | 2006 | 10 |
Why?
| Cholesterol, HDL | 1 | 2007 | 26 |
Why?
| Cholesterol, LDL | 1 | 2007 | 23 |
Why?
| Women's Health Services | 1 | 2006 | 3 |
Why?
| Piperazines | 1 | 2007 | 57 |
Why?
| Psychology, Social | 1 | 2006 | 8 |
Why?
| Meta-Analysis as Topic | 1 | 2006 | 30 |
Why?
| Parents | 1 | 2008 | 89 |
Why?
| Outpatient Clinics, Hospital | 1 | 2006 | 37 |
Why?
| SARS Virus | 1 | 2005 | 3 |
Why?
| Registries | 1 | 2006 | 84 |
Why?
| Placebo Effect | 1 | 2005 | 26 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 145 |
Why?
| Severe Acute Respiratory Syndrome | 1 | 2005 | 9 |
Why?
| Metabolic Syndrome X | 1 | 2006 | 34 |
Why?
| Social Adjustment | 1 | 2005 | 38 |
Why?
| Hispanic Americans | 1 | 2006 | 57 |
Why?
| Implosive Therapy | 1 | 2005 | 1 |
Why?
| Circadian Rhythm | 2 | 1994 | 50 |
Why?
| Group Processes | 1 | 2005 | 11 |
Why?
| Software Design | 1 | 2005 | 7 |
Why?
| Continental Population Groups | 2 | 1994 | 85 |
Why?
| Algorithms | 4 | 1994 | 226 |
Why?
| Health Personnel | 1 | 2005 | 54 |
Why?
| Regression Analysis | 2 | 1994 | 256 |
Why?
| Violence | 1 | 2005 | 31 |
Why?
| Patient Compliance | 1 | 2005 | 114 |
Why?
| Confidence Intervals | 3 | 1994 | 104 |
Why?
| Asian Americans | 1 | 2003 | 7 |
Why?
| Diabetes Mellitus | 1 | 2005 | 73 |
Why?
| Negotiating | 1 | 2003 | 2 |
Why?
| Linguistics | 1 | 2003 | 8 |
Why?
| Adaptation, Psychological | 1 | 2005 | 110 |
Why?
| Cultural Characteristics | 1 | 2003 | 19 |
Why?
| Incidence | 2 | 1994 | 337 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 121 |
Why?
| Chi-Square Distribution | 1 | 2005 | 179 |
Why?
| Urban Population | 1 | 2005 | 81 |
Why?
| Occupational Exposure | 1 | 2005 | 53 |
Why?
| Sleep Stages | 2 | 1998 | 16 |
Why?
| Cocaine-Related Disorders | 1 | 2003 | 23 |
Why?
| Survival Analysis | 2 | 1993 | 206 |
Why?
| Reference Values | 1 | 2005 | 281 |
Why?
| Gene Products, rev | 1 | 2002 | 4 |
Why?
| Gene Products, env | 1 | 2002 | 5 |
Why?
| Vaccines, DNA | 1 | 2002 | 16 |
Why?
| Recurrence | 4 | 1996 | 261 |
Why?
| Sex Factors | 3 | 1997 | 286 |
Why?
| CD8-Positive T-Lymphocytes | 2 | 1999 | 91 |
Why?
| Sleep, REM | 2 | 1998 | 8 |
Why?
| Double-Blind Method | 1 | 2005 | 274 |
Why?
| China | 3 | 2003 | 35 |
Why?
| Social Behavior | 2 | 1994 | 53 |
Why?
| Disease Models, Animal | 1 | 2005 | 349 |
Why?
| Electroencephalography | 2 | 1998 | 89 |
Why?
| Lymphocyte Activation | 2 | 1999 | 137 |
Why?
| Personality Inventory | 3 | 1996 | 53 |
Why?
| Numerical Analysis, Computer-Assisted | 1 | 1999 | 5 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 1 | 1999 | 23 |
Why?
| Smoking | 1 | 2003 | 153 |
Why?
| Friends | 2 | 2007 | 16 |
Why?
| T-Lymphocytes | 1 | 2002 | 182 |
Why?
| T-Lymphocyte Subsets | 1 | 1999 | 70 |
Why?
| Delirium, Dementia, Amnestic, Cognitive Disorders | 1 | 1997 | 15 |
Why?
| Pennsylvania | 1 | 1997 | 16 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2005 | 32 |
Why?
| Life Expectancy | 1 | 1997 | 20 |
Why?
| Blotting, Western | 1 | 1999 | 275 |
Why?
| Family | 2 | 2007 | 102 |
Why?
| Cause of Death | 1 | 1997 | 82 |
Why?
| Bipolar Disorder | 1 | 1997 | 35 |
Why?
| Health Status | 2 | 2008 | 127 |
Why?
| Disease Progression | 2 | 1994 | 244 |
Why?
| Life Style | 1 | 1997 | 55 |
Why?
| Linear Models | 2 | 2003 | 151 |
Why?
| Dose-Response Relationship, Drug | 2 | 2007 | 431 |
Why?
| Selection Bias | 1 | 1994 | 16 |
Why?
| Body Mass Index | 2 | 2005 | 122 |
Why?
| Mathematics | 1 | 1994 | 75 |
Why?
| Biological Markers | 1 | 1997 | 263 |
Why?
| Electroconvulsive Therapy | 1 | 1994 | 6 |
Why?
| Substance Abuse, Intravenous | 1 | 1993 | 16 |
Why?
| Anxiety Disorders | 1 | 1994 | 31 |
Why?
| Killer Cells, Natural | 2 | 1999 | 62 |
Why?
| HIV Seroprevalence | 1 | 1992 | 3 |
Why?
| Length of Stay | 1 | 1994 | 168 |
Why?
| Quality Control | 1 | 1992 | 54 |
Why?
| Pneumonia, Pneumocystis | 1 | 1993 | 28 |
Why?
| Proportional Hazards Models | 1 | 1993 | 123 |
Why?
| Temperance | 1 | 2010 | 4 |
Why?
| Anger | 1 | 2010 | 14 |
Why?
| North Dakota | 1 | 2010 | 2 |
Why?
| Georgia | 1 | 2010 | 9 |
Why?
| Resilience, Psychological | 1 | 2010 | 7 |
Why?
| Thrombelastography | 1 | 2010 | 3 |
Why?
| Intervention Studies | 1 | 2010 | 30 |
Why?
| Plasminogen Activators | 1 | 2010 | 21 |
Why?
| Minority Groups | 1 | 2010 | 38 |
Why?
| Schools | 1 | 2010 | 28 |
Why?
| Urokinase-Type Plasminogen Activator | 1 | 2010 | 38 |
Why?
| Fetal Blood | 1 | 2010 | 54 |
Why?
| Urban Health | 1 | 2010 | 47 |
Why?
| Cesarean Section | 1 | 2010 | 42 |
Why?
| Social Environment | 1 | 2010 | 58 |
Why?
| Microbial Sensitivity Tests | 1 | 2010 | 71 |
Why?
| Risk | 1 | 2010 | 203 |
Why?
| Patient Acceptance of Health Care | 1 | 2010 | 70 |
Why?
| Sick Role | 1 | 2009 | 26 |
Why?
| Efficiency | 1 | 2008 | 17 |
Why?
| Absenteeism | 1 | 2008 | 26 |
Why?
| Wakefulness | 2 | 1998 | 16 |
Why?
| Patient Satisfaction | 1 | 2010 | 120 |
Why?
| Curriculum | 1 | 2010 | 127 |
Why?
| Family Health | 1 | 2008 | 69 |
Why?
| Cytomegalovirus | 1 | 2008 | 42 |
Why?
| Outpatients | 1 | 2007 | 29 |
Why?
| Immunity, Innate | 1 | 2008 | 60 |
Why?
| Interview, Psychological | 1 | 2007 | 38 |
Why?
| Panic Disorder | 1 | 2006 | 3 |
Why?
| Models, Psychological | 1 | 2007 | 45 |
Why?
| Denmark | 1 | 2006 | 9 |
Why?
| Weight Loss | 1 | 2007 | 52 |
Why?
| Herpesvirus 6, Human | 1 | 2008 | 22 |
Why?
| Statistics as Topic | 1 | 2007 | 133 |
Why?
| Psychotropic Drugs | 1 | 2006 | 30 |
Why?
| Cerebrovascular Disorders | 1 | 2007 | 66 |
Why?
| Drug Evaluation | 1 | 2006 | 54 |
Why?
| Multicenter Studies as Topic | 1 | 2006 | 70 |
Why?
| Nutrition Surveys | 1 | 2006 | 36 |
Why?
| African Continental Ancestry Group | 1 | 2007 | 80 |
Why?
| Prognosis | 1 | 2009 | 389 |
Why?
| Cost of Illness | 1 | 2006 | 54 |
Why?
| Neuropsychological Tests | 1 | 2007 | 114 |
Why?
| Lung Diseases, Interstitial | 1 | 2005 | 12 |
Why?
| Pharynx | 1 | 2005 | 23 |
Why?
| Workplace | 1 | 2005 | 16 |
Why?
| Occupational Health | 1 | 2005 | 16 |
Why?
| Infant, Newborn | 1 | 2010 | 389 |
Why?
| Great Britain | 1 | 2005 | 49 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2008 | 113 |
Why?
| Safety | 1 | 2005 | 80 |
Why?
| Microscopy, Electron | 1 | 2005 | 178 |
Why?
| Evidence-Based Medicine | 1 | 2006 | 125 |
Why?
| Adipose Tissue | 1 | 2005 | 80 |
Why?
| Hypnotics and Sedatives | 1 | 2005 | 45 |
Why?
| Macaca mulatta | 1 | 2005 | 71 |
Why?
| Drug Administration Schedule | 1 | 2005 | 193 |
Why?
| Lymphocytes | 1 | 2005 | 142 |
Why?
| Communication Barriers | 1 | 2003 | 21 |
Why?
| Hemorrhage | 1 | 2005 | 103 |
Why?
| Blood Glucose | 1 | 2005 | 99 |
Why?
| RNA, Viral | 1 | 2005 | 91 |
Why?
| rev Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 3 |
Why?
| Virus Replication | 1 | 2005 | 90 |
Why?
| Pulmonary Alveoli | 1 | 2005 | 80 |
Why?
| Recovery of Function | 1 | 2003 | 91 |
Why?
| Macrophages | 1 | 2005 | 148 |
Why?
| Immunoglobulin G | 1 | 2005 | 192 |
Why?
| Immunity, Cellular | 1 | 2002 | 85 |
Why?
| AIDS Vaccines | 1 | 2002 | 18 |
Why?
| Attitude of Health Personnel | 1 | 2005 | 165 |
Why?
| Antibody Formation | 1 | 2002 | 90 |
Why?
| Device Approval | 1 | 2001 | 7 |
Why?
| Child, Preschool | 1 | 2008 | 555 |
Why?
| United States Food and Drug Administration | 1 | 2001 | 28 |
Why?
| Muromonab-CD3 | 1 | 1999 | 4 |
Why?
| Cytotoxicity Tests, Immunologic | 1 | 1999 | 23 |
Why?
| Lymphocyte Count | 1 | 1999 | 38 |
Why?
| Antigens, CD3 | 1 | 1999 | 37 |
Why?
| Delta Rhythm | 1 | 1998 | 4 |
Why?
| Remission Induction | 1 | 1999 | 64 |
Why?
| Lung | 1 | 2005 | 233 |
Why?
| Sampling Studies | 1 | 1996 | 41 |
Why?
| Confidentiality | 1 | 1996 | 14 |
Why?
| Personality Assessment | 1 | 1997 | 30 |
Why?
| Demography | 1 | 1994 | 87 |
Why?
| Dysthymic Disorder | 1 | 1994 | 3 |
Why?
| Arousal | 1 | 1994 | 38 |
Why?
| Animals | 1 | 2005 | 1032 |
Why?
|
|
Tu's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
